TruBridge, Inc. (TBRG) Stock Analysis

Company Overview

TruBridge, Inc. operates within the healthcare sector, specifically serving community hospitals, clinics, and various healthcare systems both domestically and internationally by delivering specialized solutions and services. The company functions primarily within the health information services industry, where it provides critical revenue cycle management (RCM) solutions alongside other operational support for its clients. This entity maintains a significant operational scale with a market capitalization of $219.17M and an annual revenue of $347.27M, supported by a workforce of 3200 employees. These valuation and revenue figures indicate that TruBridge holds a substantial position in its niche, managing complex financial and patient care operations across a broad geographic footprint that includes international markets.

Financial Health

TruBridge, Inc. reported a trailing twelve-month revenue of $347.27M with a corresponding net income of $3.50M and an EBITDA of $46.34M, highlighting a substantial disparity between top-line generation and bottom-line profitability. The significant gap between the $347.27M in revenue and the $3.50M in net income reveals a cost structure where operating expenses, including salaries, technology infrastructure, and administrative costs, consume the vast majority of generated income before reaching the profit line. The company generated $32.00M in free cash flow, which provides a tangible measure of financial flexibility to fund capital expenditures, manage debt obligations, or pursue strategic acquisitions without immediate reliance on external financing. Profitability metrics show a gross margin of 52.8%, indicating strong pricing power or cost advantages in direct costs, while an operating margin of 9.0% and a profit margin of 1.0% suggest high leverage of fixed costs relative to sales volume. On the balance sheet, the company holds $19.92M in cash against $166.86M in debt, resulting in a debt-to-equity ratio of 92.52 which characterizes a highly leveraged financial structure rather than a conservative one. Despite the high leverage, a current ratio of 1.91 indicates that the company maintains sufficient short-term assets to cover its short-term liabilities, ensuring adequate liquidity for day-to-day operations. Return on equity stands at 2.0% and return on assets is 5.1%, metrics that reveal management's current effectiveness in generating returns relative to the capital invested and the total asset base utilized.

Valuation Assessment

The trailing twelve-month P/E ratio is 60.83, while the forward P/E is significantly lower at 6.36, implying that the market expects a dramatic and rapid expansion in earnings per share over the coming year to justify the current multiple. The price-to-book ratio is 1.18, indicating that the market values the company slightly above its net asset book value, suggesting a modest premium for its intangible assets and service capabilities. Alternative valuation metrics include a price-to-sales ratio of 0.63 and an EV/EBITDA of 7.75, which suggest the company is trading at a multiple that reflects its high cash flow generation relative to enterprise value despite low current profitability. Regarding recent price action, the 52-week high is $29.78 and the 52-week low is $14.41, placing the current trading price within this historical range and reflecting the stock's recent volatility. The beta value is 0.65, which indicates that the stock's price volatility is historically lower than that of the broader market, suggesting a more defensive characteristic in its price movements relative to general market swings.

Growth & Income

Revenue growth year-over-year is recorded at 1.7%, while earnings growth is listed as N/A, indicating that the company is currently in a phase where revenue expansion outpaces any measurable earnings growth due to the low current profit margin. Because the company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, all available earnings are theoretically available for reinvestment into business growth or debt reduction rather than distribution to shareholders. The absence of a dividend payout ratio implies that the company prioritizes retaining capital to fund operations and potentially reduce its significant debt load over time. Overall, the growth and income profile is defined by modest revenue expansion and a complete lack of dividend income, characteristic of a capital-intensive growth stage in the healthcare services sector.